Dr. Sven Olek
Founder and Chief Executive Officer
Sven received a B.Sc. from the Imperial College of Science, Technology, and Medicine, London, UK and a Ph.D. in Biochemistry from the University of London. He did pre- and post-doctoral research at the ZMBH, University of Heidelberg and at R.W. Johnson Pharmaceutical Research Institute in San Diego, USA. Sven is inventor on the patents forming the basis of the intellectual property of Epiontis and has been heading Epiontis since its foundation in 2003.
Dr. Ulrich Hoffmueller, MBA
Ulrich received a Diploma (Masters) in Biochemistry in 1995 from Humboldt University in Berlin, Germany. He earned a Ph.D. at the Charité University Clinic in Berlin in 1998 and was honored with the Charité Research Award in 1997. Ulrich completed business school in Berlin and Cambridge, UK from 2002 to 2004. Prior to co-founding Epiontis in 2003, he worked at Jerini AG in Berlin from 1999 to 2003, most recently as Director of Business Development.
Helge studied Business Economics in Mannheim (Diploma) from 1993 to 1996. From 1996 to 1998, he was active for an automotive company, responsible for product management. From 1998 to 2000, Helge headed the financial department of a Biotech Company. In 2001, he co-founded an IT start-up and served within this company until 2005 in various positions, including Chief Financial officer. In 2006, Helge joined Epiontis and was nominated as CFO in 2012.